Menu

Cholera Confusion, circa 1832

As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.

Feb 1, 2013
Dan Cossins

WARDING OFF CHOLERA: Printed in Nuremberg, Germany, around 1832, this depiction of a woman’s attempts to repel cholera satirizes the abundance of dubious advice about prevention. Little was known about the disease when it first arrived in Europe, but by the end of the 19th century, physician-scientists had identified the culprit bacterium, rendering homemade prevention methods obsolete.THE FRANCIS A. COUNTWAY LIBRARY OF MEDICINE, HARVARD MEDICAL LIBRARYAll the way from the Ganges River delta in India, an unwelcome visitor arrived in Europe in 1831. Its victims suffered violent cramps, vomiting, and diarrhea, along with dehydration so rapid and severe that their skin was rendered a deathly blue. Many died within hours of the first symptoms.

Cholera was one of the most devastating diseases to hit Europe in the 19th century, with a series of epidemics taking hundreds of thousands of lives. And because its cause was a mystery, people were prepared to take any measure to keep it at bay. “They tried all manner of things,” says Christopher Hamlin, a science historian at the University of Notre Dame in Indiana and author of Cholera: The Biography.

Leading theories at the time held that the disease was caught through exposure to foul or filthy air, so measures designed to repel cholera by purifying the air were particularly common, as depicted in this satirical cartoon of a woman extravagantly equipped with chlorinated lime, garlic, various herbs, and vinegar bags. “Anything that tended to change the quality of the air was plausible as a preventative measure,” says Hamlin.

But by the 1850s, this so-called “miasmatic” explanation for cholera had a challenger: the idea that the disease was caused by contaminated water. In 1854, in what is now feted as the dawn of epidemiology, British physician John Snow traced the source of an outbreak in Soho, London, to a water pump on Broad Street. When the pump handle was removed, cholera cases quickly disappeared.

The same year, Italian anatomist and germ theory pioneer Filippo Pacini  identified a comma-shaped bacillus he named “Vibrio” while examining the intestinal mucosa of dead cholera victims under the microscope. His findings were largely ignored at the time, however, so it was left to the German physician-scientist Robert Koch to claim the credit for the discovery. He identified the same microbe in Egypt in 1884 and, working in India a few months later, reported that the bacilli were always found in patients with cholera, but never in those with diarrhea from other causes.

Koch’s findings did not immediately put an end to the use of air purification measures, as many still clung to the miasmatic explanation. But by the end of the 19th century, cholera was known to be caused by a microbe. The vinegar bags were on the way out, while improved sanitation and a vaccine—first developed for cholera by Waldemer Haffkine in 1892—were emerging as new methods for preventing this dreaded disease.
 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.